Loading...

UCB SA

UCBJFPNK
Healthcare
Biotechnology
$199.89
$0.00(0.00%)

UCB SA (UCBJF) Financial Performance & Statements

Review UCB SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.

Revenue Growth
17.14%
17.14%
Operating Income Growth
119.21%
119.21%
Net Income Growth
210.50%
210.50%
Operating Cash Flow Growth
63.21%
63.21%
Operating Margin
9.15%
9.15%
Gross Margin
65.90%
65.90%
Net Profit Margin
4.40%
4.40%
ROE
2.53%
2.53%
ROIC
3.61%
3.61%

UCB SA (UCBJF) Financial Statements

Explore quarterly and annual reports including balance sheet, income statement, cash flow for UCB SA stock.

MetricQ2 2024Q4 2023Q3 2023Q2 2023
Revenue$2.79B$2.66B$1.33B$2.59B
Cost of Revenue$851.00M$1.009B$452.50M$901.00M
Gross Profit$1.94B$1.65B$879.00M$1.69B
Gross Profit Ratio$0.70$0.62$0.66$0.65
R&D Expenses$789.00M$871.00M$435.50M$759.00M
SG&A Expenses$1.07B$863.00M$483.50M$758.00M
Operating Expenses$1.62B$1.48B$826.00M$1.21B
Total Costs & Expenses$2.47B$2.49B$1.28B$2.11B
Interest Income$15.00M$31.00M$33.00M$16.00M
Interest Expense$92.00M$115.00M$0.00$95.00M
Depreciation & Amortization$318.00M$376.00M$188.00M$315.00M
EBITDA$644.00M$552.00M$270.50M$794.00M
EBITDA Ratio$0.23$0.21$0.20$0.31
Operating Income$323.00M$176.00M$82.50M$479.00M
Operating Income Ratio$0.12$0.07$0.06$0.19
Other Income/Expenses (Net)-$77.00M-$156.00M-$62.50M-$278.50M
Income Before Tax$246.00M$40.00M$20.00M$401.00M
Income Before Tax Ratio$0.09$0.02$0.02$0.15
Income Tax Expense$38.00M$8.00M$4.00M$90.00M
Net Income$208.00M$32.00M$16.00M$311.00M
Net Income Ratio$0.07$0.01$0.01$0.12
EPS$1.10$0.17$0.08$1.64
Diluted EPS$1.07$0.16$0.08$1.60
Weighted Avg Shares Outstanding$189.89M$189.78M$195.99M$189.26M
Weighted Avg Shares Outstanding (Diluted)$195.007M$199.62M$195.63M$194.75M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;